Evidence map›Paper›PMID 36681079›Full record

ArticleCell2023

Cyclin E-induced replicative stress drives p53-dependent whole-genome duplication.

Jingkun Zeng, Stephanie A Hills, Eiko Ozono, John F X Diffley

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
27.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 134 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. RHAMM drives formation of polyploid cancer cells and confers resistance to ER-targeted therapy in breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Growth under pressure: The pros and cons of polyploidy induced by stress.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jingkun ZengChromosome Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Stephanie A HillsChromosome Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Eiko OzonoChromosome Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
John F X DiffleyChromosome Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK. Electronic address: john.diffley@crick.ac.uk.
The Francis Crick Institute · GB

Funding

Cancer Research UKMedical Research CouncilWellcome Trust 106252/Z/14/ZWellcome Trust FC001066
6 · The paper itself

Abstract

Whole-genome duplication (WGD) is a frequent event in cancer evolution and an important driver of aneuploidy. The role of the p53 tumor suppressor in WGD has been enigmatic: p53 can block the proliferation of tetraploid cells, acting as a barrier to WGD, but can also promote mitotic bypass, a key step in WGD via endoreduplication. In wild-type (WT) p53 tumors, WGD is frequently associated with activation of the E2F pathway, especially amplification of CCNE1, encoding cyclin E1. Here, we show that elevated cyclin E1 expression causes replicative stress, which activates ATR- and Chk1-dependent G2 phase arrest. p53, via its downstream target p21, together with Wee1, then inhibits mitotic cyclin-dependent kinase activity sufficiently to activate APC/C

Indexed as

Cyclin EGene DuplicationNeoplasmsTumor Suppressor Protein p53Cell Line, TumorCyclin-Dependent Kinase Inhibitor p21HumansMitosisOncogene ProteinsCCNE1 protein, humanCyclin-Dependent Kinase Inhibitor p21Cyclin EOncogene ProteinsTP53 protein, humanTumor Suppressor Protein p53aneuploidycancer biologycell cyclecyclin EDNA replicationmitotic bypasswhole-genome duplication

Identifiers

PMID36681079
PMCPMC7619399
OpenAlexW4317708751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.